03.07.2012 • News

GEA Pharma Systems Wins Large Order for Continuous Solid Dose Processing

GEA Pharma Systems has announced an agreement with a US pharmaceutical company to supply a complete continuous processing line for the production of solid dose drugs. The order is one of the more significant for Consigma oral solid dosage continuous processing equipment and represents the first phase of a potentially long-term commitment for this customer. Delivery is scheduled for early 2013.

The order is to deliver a continuous solid dosage production platform, including continuous blending, wet granulation and drying, dry granulation and direct compression. In addition to the Courtoy Modul tablet press and a tablet relaxation module, the system will also include the first commercial continuous GEA coater. The entire line will be equipped with a range of PAT instruments (partly based on the GEA's patented Lighthouse Probe technology) for on-line measurement of particle size distribution, humidity, blend/content uniformity and coating quality. This data will be captured in an overall control and information system which allows for 'real-time-release' of the finished tablets.

 

 

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.